Benzinga's Top Downgrades

Analysts at Morgan Stanley downgraded Cliffs Natural Resources

from “equal weight” to “underweight.” The target price for Cliffs Natural has been lowered from $36 to $14. Cliffs Natural's shares closed at $21.43 yesterday. Analysts at Brinson Patrick downgraded ZIOPHARM Oncology

from “outperform” to “market perform.” The target price for ZIOPHARM Oncology has been lowered from $7 to $1.50. ZIOPHARM Oncology's shares closed at $1.82 yesterday. Analysts at Keefe Bruyette & Woods downgraded Western Alliance Bancorporation

from “outperform” to “market perform.” The target price for Western Alliance Bancorporation has been raised from $13.50 to $15. Western Alliance Bancorporation's shares closed at $13.98 yesterday. Sterne Agee downgraded Sun Bancorp

from “neutral” to “underperform.” The target price for Sun Bancorp is set to $2.50. Sun Bancorp's shares closed at $3.70 yesterday.